Aeglea BioTherapeutics
Austin
About Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that address rare genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $266.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2023)
- Ticker: nasdaq:AGLE
- Website: aeglea.com
- Phone: +1 512 942 2935
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aeglea-biotherapeutics-192065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.